Current concepts in the management of amblyopia

Blanca Ruiz de Zárate, Jaime Tejedor, Blanca Ruiz de Zárate, Jaime Tejedor

Abstract

Traditional treatment of amblyopia, although still in use and of great value, has recently been challenged by data from studies relative to efficacy of different modalities and regimens of therapy. LogMAR-based acuity charts should be used, whenever possible, for diagnosis and monitoring. Refractive errors of certain magnitude should be prescribed, and correction worn for at least 4 months before occlusion or penalization are used. Occlusion has a linear dose-response effect (1 logMAR line gain per 120 hours of patching), and outcomes of 2 hour/day dosage are similar to more extended therapy, at least in moderate amblyopia, but increasing dosage beyond hastens the response. Pharmacologic, optical, or combined penalization is useful as an alternative or maintaining therapy, and is presumably of particular efficacy in anisometropic amblyopia. At least in moderate amblyopia, atropine penalization is as effective as patching in terms of visual acuity improvement and stereoacuity outcome.

Keywords: amblyopia; anisometropia; refractive error; strabismus.

References

    1. Allen HF. A new picture series for preschool vision testing. Am J Ophthalmol. 1957;44:38–41.
    1. American Academy of Ophthalmology . San Francisco, Calif: American Academy of Ophthalmology; 2002. Preferred Practice Pattern: Amblyopia.
    1. Atilla H, Oral D, Coskun S, et al. Poor correlation between “fix-follow-maintain” monocular/binocular fixation pattern evaluation and presence of functional amblyopia. Binocul Vis Strabismus Q. 2001;16:85–90.
    1. Atkinson J, Braddick O. Assesment of visual acuity in infancy and early childhood. Acta Ophthalmol Scand Suppl. 1983:18–26.
    1. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003;135:194–205.
    1. Becker R, Hübsch S, Gräf MH, et al. Examination of young children with Lea symbols. Br J Ophthalmol. 2002;86:513–16.
    1. Becker R, Gräf M. Landolt C and Snellen e acuity: differences in strabismus amblyopia. Klin Monatsbl Augenheilkd. 2006;223:24–8.
    1. BenEzra O, Herzog R, Cohen E, et al. Liquid crystal glasses: feasibility and safety of a new modality for treating amblyopia. Arch Ophthalmol. 2007;125:580–1.
    1. Bhartiya P, Sharma P, Biswas NR. Levodopa-carbidopa with occlusion in older children with amblyopia. J AAPOS. 2002;6:368–72.
    1. Bhola R, Keech RV, Kutschke P, et al. Recurrence of amblyopia after occlusion therapy. Ophthalmology. 2006;113:2097–100.
    1. Browder JA, Levy WJ. Vision testing of young and retarded children. Experience with the British STYCAR screening test. Clin Pediatr. 1974;13:983–6.
    1. Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007;143:54–60.
    1. Chua B, Mitchell P. Consequences of amblyopia on education, occupation and long term vision loss. Br J Ophthalmol. 2004;88:1119–21.
    1. Clarke MP, Wright CM, Hrisos S, et al. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ. 2003;327:1251–6.
    1. Cleary M. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified. Br J Ophthalmol. 2000;84:572–7.
    1. Cotter SA, Edwars AR, Wallace DK, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006;113:895–903.
    1. Cotter SA, Edwars AR, Arnold RW, et al. Treatment of strabismic amblyopia with refractive correction. Am J Ophthalmol. 2007;143:1060–3.
    1. Eustis HS, Chamberlain D. Treatment for amblyopia: results using occlusive contact lens. J Pediatr Ophthalmol Strabismus. 1996;33:319–22.
    1. Ferris FL, III, Kassof A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91–6.
    1. Flynn JT, Woodruff G, Thompson JR, et al. The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets. Trans Am Ophthalmol Soc. 1999;97:373–90.
    1. Foley-Nolan A, McCann A, O’Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol. 1997;81:54–7.
    1. France TD, France LW. Optical penalization can improve vision after occlusion treatment. J AAPOS. 1999;3:341–3.
    1. Getz LM, Dobson V, Luna B, et al. Interobserver reliability of the Teller Acuity Card procedure in pediatric patients. Invest Ophthalmol Vis Sci. 1996;37:180–7.
    1. Gottlob I, Wizov SS, Reinecke RD. Visual acuities and scotomas after 3 weeks’ levodopa administration in adult amblyopia. Graefes Arch Clin Exp Ophthalmol. 1995;233:407–13.
    1. Gräf M, Becker R, Kaufmann H. Lea symbols: visual acuity assessment and detection of amblyopia. Graefes Arch Clin Exp Ophthalmol. 2000;238:53–8.
    1. Gregson R. Why are we so bad at treating amblyopia. Eye. 2002;16:461–2.
    1. Grimm W, Rassow B, Wesemann W, et al. Correlation of optotypes with the Landolt ring, a fresh look at the comparability of optotypes. Optom Vis Sci. 1994;71:6–13.
    1. Harvey EM, Dobson V, Tung B, et al. Interobserver agreement for grating acuity and letter acuity assessment in 1-to 5.5-years-old with severe retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1999;40:1565–76.
    1. Hazell CD. Evaluation of the Cardiff acuity test in uniocular amblyopia. Br Orthopt J. 1995;52:8–15.
    1. Hered RW, Murphy S, Clancy M. Comparison of the HOTV and Lea Symbols charts for preschool vision screening. J Pediatr Ophthalmol Strabismus. 1997;34:24–8.
    1. Hillis A, Flynn JT, Hawkins BS. The evolving concept of amblyopia a challenge to epidemiologists. Am J Epidemiol. 1983;118:192–205.
    1. Holmes JM, Beck RW, Repka MX, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol. 2001;119:1345–53.
    1. Hubel DH, Wiesel TN. The period of susceptibility to the physiological effects of unilateral eye closure in Kittens. J Physiol. 1970;206:419–36.
    1. Hyvarinen L, Nasanen R, Laurinen P. New visual acuity test for pre-school children. Acta Ophthalmologica. 1980;58:507–11.
    1. Kay H. New method of assessing visual acuity with pictures. Br J Ophthalmol. 1983;67:131–3.
    1. Kaye SB, Chen SI, Price G, et al. Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia. J AAPOS. 2002;6:289–93.
    1. Klimek DL, Cruz OA, Scott WE, et al. Isoametropic amblyopia due to high hyperopia in children. J AAPOS. 2004;8:310–13.
    1. König HH, Barry JC. Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model. Br J Ophthalmol. 2004;88:606–12.
    1. Kutschke PJ, Scott WE, Keech RV. Anisometropic amblyopia. Ophthalmology. 1991;98:258–63.
    1. Kvarnström G, Jakobsson P, Lennerstrand G. Visual screening of Swedish children: an ophthalmological evaluation. Acta Ophthalmol Scand. 2001;79:240–4.
    1. Lam GC, Repka MX, Guyton DL. Timing of amblyopia therapy relative to strabismus surgery. Ophthalmology. 1993;100:1751–6.
    1. Leguire LE, Komaromy KL, Nairus TM, et al. Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus. 2002;39:326–30.
    1. Levartovsky S, Gottesman N, Shimshoni M, et al. Factors affecting long-term results of successfully treated amblyopia: age at beginning of treatment and age at cessation of monitoring. J Pediatr Ophthalmol Strabismus. 1992;29:219–23.
    1. Levartovsky S, Oliver M, Gottesman N, et al. Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia. Br J Ophthalmol. 1995;79:225–8.
    1. Mayer DL, Fulton AB, Rodier D. Grating and recognition acuities of pediatric patients. Ophthalmology. 1984;91:947–53.
    1. McGraw PV, Winn B. Glasgow acuity cards: a new test for the measurement of letter acuity in children. Ophthalmic Physiol Opt. 1993;13:400–4.
    1. McGraw PV, Winn B, Gray LS, et al. Improving the reliability of visual acuity measures in young children. Ophthalmic Physiol Opt. 2000;20:173–84.
    1. Membreno JH, Brown MM, Brown GC, et al. A cost-utility analysis of therapy for amblyopia. Ophthalmology. 2002;109:2265–71.
    1. Mintz–Hittner H, Fernandez K. Succesful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol. 2000;118:1535–41.
    1. Moke PS, Turpin AH, Beck RW, et al. Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol. 2001;132:903–9.
    1. Morad Y, Werker E, Nemet P, et al. Visual acuity tests using chart, line, and single optotype in healthy and amblyopic children. J AAPOS. 1999;3:94–7.
    1. Morrison DG, Palmer NJ, Sinatra RB, et al. Severe amblyopia of the sound eye resulting from atropine therapy combined with optical penalization. J Pediatric Ophthalmol Strabismus. 2005;42:52–3.
    1. Moseley MJ, Neufeld M, Fielder AR. Treatment of amblyopia by spectacles. Invest Ophthalmol Vis Sci. 1998;39:S332.
    1. Moseley MJ, Neufeld M, McCarry B, et al. Remediation of refractive amblyopia by optical correction alone. Ophthalmic Physiol Opt. 2002;22:296–9.
    1. Nilsson J, Baumann M, Sjöstrand J. Strabismus might be a risk factor for amblyopia recurrence. J AAPOS. 2007;11:240–2.
    1. North RV, Kelly ME. A review of the uses and adverse effects of topical administration of atropine. Ophthalmol Physiol Opt. 1987;7:109–14.
    1. Oster JG, Simon JW, Jenkins P. When is it safe to stop patching. Br J Ophthalmol. 1990;74:709–11.
    1. Pandey PK, Chaudhuri Z, Kumar M. Effect of levodopa and carbidopa in human amblyopia. J Pediatr Ophthamol Strabismus. 2002;39:81–9.
    1. Park KH, Hwang J-M, Ahn JK. Efficacy of amblyopia therapy initiated after 9 years of age. Eye. 2004;18:571–4.
    1. Paysse EA, Coats DK, Hussein MA, et al. Long term outcomes of photorefractive Keratectomy for anisometropic amblyopia in children. Ophthalmology. 2006;113:169–76.
    1. [PEDIG] Pediatric Eye Disease Investigator Group A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Opthalmol. 2002;120:268–78.
    1. [PEDIG] Pediatric Eye Disease Investigator Group The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. Am J Ophthalmol. 2003a;136:630–9.
    1. [PEDIG] Pediatric Eye Disease Investigator Group A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003b;110:2075–87.
    1. [PEDIG] Pediatric Eye Disease Investigator Group A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003c;121:603–11.
    1. [PEDIG] Pediatric Eye Disease Investigator Group Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study. Arch Ophthalmol. 2003d;121:1625–32.
    1. [PEDIG] Pediatric Eye Disease Investigator Group A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthamology. 2004a;111:2076–85.
    1. [PEDIG] Pediatric Eye Disease Investigator Group Risk of amblyopia recurrence after cessation of treatment. J AAPOS. 2004b;8:420–8.
    1. [PEDIG] Pediatric Eye Disease Investigator Group Two-year follow up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005a;123:149–57.
    1. [PEDIG] Pediatric Eye Disease Investigator Group Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005b;123:437–47.
    1. [PEDIG] Pediatric Eye Disease Investigator Group A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS. 2005c;9:129–36.
    1. Rahi J, Logan S, Timms C, et al. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet. 2002;360:597–602.
    1. Rassow B, Wang Y. Correlation of letter optotypes with Landolt ring for different degrees of visual acuity. Klin Monatsbl Augenheilkd. 1999;215:119–26.
    1. Repka MX, Gallin PF, Scholz RT, et al. Determination of optical penalization by vectographic fixation reversal. Ophthalmology. 1985;92:1584–6.
    1. Rydberg A, Ericson B. Assessing visual function in children younger than 1½ years with normal and subnormal vision: evaluation of methods. J Pediatr Ophthalmol Strabismus. 1998;35:312–19.
    1. Ruttum MS, Dahlgren M. Comparison of HOTV and Lea symbols visual acuity tests in patients with amblyopia. J Pediatr Ophthalmol Strabismus. 2006;43:157–60.
    1. Rydberg A, Ericson B, Lennerstrand G, et al. Assesment of visual acuity in children aged 1½-6 years, with normal and subnormal vision. Strabismus. 1999;7:1–24.
    1. Searle A, Norman P, Harrad R, et al. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye. 2002;16:150–5.
    1. Simons K, Stein L, Sener EC, et al. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology. 1997a;104:2143–55.
    1. Simons K, Gotzler KC, Vitale S. Penalization vs part-time occlusion and binocular outcome in treatment of strabismic amblyopia. Ophthalmology. 1997b;104:2156–60.
    1. Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol. 1999;83:582–7.
    1. Snowdon SK, Stewart-Brown SL. Preschool vision screening. Health Technol Assess. 1997;1:1–83.
    1. Stewart CE, Moseley MJ, Fielder AR, et al. MOTAS Cooperative Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol. 2004a;88:1552–6.
    1. Stewart CE, Moseley MJ, Stephens DA, et al. Treatment Dose-Response in Amblyopia Therapy: The Monitored Occlusion Treatment Of Amblyopia Study (MOTAS) Invest Ophthalmol Vis Sci. 2004b;45:3048–54.
    1. Tommila V, Tarkkanen A. Incidence of loss of vision in the healthy eye in amblyopia. Br J Ophthalmol. 1981;65:575–7.
    1. Tychsen L, Packwood E, Berdy G. Correction of large amblyopiogenic refractive errors in children using excimer laser. J AAPOS. 2005;9:224–33.
    1. Van Leeuwen R, Eijkemans MJ, Vingerling JR, et al. 2007Risk of bilateral visual impairment in persons with amblyopia: The Rotterdam Study Br J Ophthalmol, doi:10.1136/bjo.2006.113670.
    1. Von Noorden GK, Crawford ML. The sensitive period. Trans Ophthalmol Soc UK. 1979;99:442–6.
    1. Von Noorden GK. Binocular Vision and Ocular Motility. St Lous: Mosby; 1996.
    1. Wallace D. Tests of fixation preference for amblyopia. Am Orthopt J. 2005;55:76–81.
    1. Weakley DR., Jr The association between nonstrabismic anisometropia, amblyopia, and subnormal binocularity. Ophthalmology. 2001;108:163–71.
    1. Woodhouse JM, Morjaria SA, Adler PM. Acuity measurements adult subjects using a preferential looking test. Ophthalmic Physiol Opt. 2007;27:54–9.
    1. Wright KW, Edelman PM, Walonker F, et al. Reliability of fixation preference testing in diagnosing amblyopia. Arch Ophthalmol. 1986;104:549–53.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다